Increased serum interleukin-32 levels in patients with Behçet's disease.

about

Interleukin-32: its role in asthma and potential as a therapeutic agent.The Biology and Role of Interleukin-32 in Tuberculosis

P2860

Q55479672-B781DCB8-E96A-4689-BEE7-6481AE9BB2B7 Q58694023-9AE18767-358B-4D5A-A76B-90D9C990CA69

P2860

Increased serum interleukin-32 levels in patients with Behçet's disease.

Item

http://www.wikidata.org/entity/Q48318960

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Increased serum interleukin-32 levels in patients with Behçet's disease.

@en

Increased serum interleukin-32 levels in patients with Behçet's disease.

@nl

type

Item

label

Increased serum interleukin-32 levels in patients with Behçet's disease.

@en

Increased serum interleukin-32 levels in patients with Behçet's disease.

@nl

prefLabel

Increased serum interleukin-32 levels in patients with Behçet's disease.

@en

Increased serum interleukin-32 levels in patients with Behçet's disease.

@nl

P1476

Increased serum interleukin-32 levels in patients with Behçet's disease.

@en

P2093

Jin-Su Park

http://www.w3.org/2001/XMLSchema#string

Mi-Il Kang

http://www.w3.org/2001/XMLSchema#string

Soo-Kon Lee

http://www.w3.org/2001/XMLSchema#string

Yong-Beom Park

http://www.w3.org/2001/XMLSchema#string

P2860

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis

Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51

IL-32, a proinflammatory cytokine in rheumatoid arthritis.

Cross-cultural adaptation and validation of the Behcet's Disease Current Activity Form in Korea

Interleukin-32 induces the differentiation of monocytes into macrophage-like cells.

Behçet's syndrome pathophysiology and potential therapeutic targets.

A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.

Pathogenesis of Behçet's disease: autoinflammatory features and beyond.

A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.

P304

2167-2174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1756-185X.13072

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

You-Jung Ha

Sang-Won Lee

P577

2017-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28378461

http://www.w3.org/2001/XMLSchema#string

P921

Behcet's disease

Increased serum interleukin-32 levels in patients with Behçet's disease.

about

P2860

P2860

Increased serum interleukin-32 levels in patients with Behçet's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921